MENU
+Compare
XOMA
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$35.24
Change
-$0.16 (-0.45%)
Capitalization
425.97M

XOMA XOMA Royalty Corporation Forecast, Technical & Fundamental Analysis

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health... Show more

Industry: #Biotechnology
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for XOMA with price predictions
Sep 04, 2025

XOMA in upward trend: 10-day moving average moved above 50-day moving average on August 04, 2025

The 10-day moving average for XOMA crossed bullishly above the 50-day moving average on August 04, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 04, 2025. You may want to consider a long position or call options on XOMA as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for XOMA just turned positive on August 05, 2025. Looking at past instances where XOMA's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

XOMA moved above its 50-day moving average on August 08, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for XOMA moved above the 200-day moving average on August 05, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XOMA advanced for three days, in of 274 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 205 cases where XOMA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XOMA broke above its upper Bollinger Band on August 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.610) is normal, around the industry mean (19.994). P/E Ratio (0.000) is within average values for comparable stocks, (51.700). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.020) settles around the average of (0.044) among similar stocks. P/S Ratio (33.003) is also within normal values, averaging (325.279).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XOMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

XOMA is expected to report earnings to fall 119.32% to -8 cents per share on November 06

XOMA Royalty Corporation XOMA Stock Earnings Reports
Q3'25
Est.
$-0.09
Q2'25
Beat
by $0.64
Q1'25
Beat
by $0.35
Q4'24
Beat
by $0.25
Q3'24
Missed
by $1.15
The last earnings report on August 13 showed earnings per share of 43 cents, beating the estimate of -20 cents. With 33.36K shares outstanding, the current market capitalization sits at 425.97M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical preparations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2200 Powell Street
Phone
+1 510 204-7200
Employees
13
Web
https://www.xoma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OPOCX104.070.58
+0.56%
Invesco Discovery A
NGRRX34.840.13
+0.37%
Nuveen International Value I
DLBMX17.900.03
+0.17%
MassMutual Small Cap Opps A
SBQIX8.79N/A
N/A
AmericaFirst Alpha Trends Factor Class I
GGGPX44.19N/A
N/A
Goldman Sachs Large Cap Equity P

XOMA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMA has been loosely correlated with SYRE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMA
1D Price
Change %
XOMA100%
+1.55%
SYRE - XOMA
40%
Loosely correlated
+1.07%
CGEM - XOMA
39%
Loosely correlated
-10.49%
OLMA - XOMA
39%
Loosely correlated
+0.95%
ARWR - XOMA
38%
Loosely correlated
+0.72%
RCUS - XOMA
37%
Loosely correlated
-0.69%
More